Dolby Laboratories, INC. (DLB) — SEC Filings

Overview

Dolby Laboratories, INC. (DLB) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a DEF 14A filed on Dec 16, 2025: Dolby Laboratories, Inc. (DLB) reported total revenue of $1.35 billion for fiscal 2025, a 6.3% increase from $1.27 billion in fiscal 2024. Despite this revenue growth, GAAP net income decreased by 2.6% to $255.0 million from $261.8 million in the prior year. However, non-GAAP net income saw a signif

Sentiment Summary

Across 30 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 27 neutral, 1 mixed. The dominant filing sentiment for Dolby Laboratories, INC. is neutral.

Filing Type Overview

Dolby Laboratories, INC. (DLB) has filed 2 DEF 14A, 2 10-K, 14 8-K, 6 10-Q, 6 SC 13G/A with the SEC between Jan 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (30)

• Dolby's Revenue Climbs 6.3% to $1.35B, Boosts Dividend 9% — DEF 14A · Dec 16, 2025 Risk: medium
  Dolby Laboratories, Inc. (DLB) reported total revenue of $1.35 billion for fiscal 2025, a 6.3% increase from $1.27 billion in fiscal 2024. Despite this revenue
• Dolby's Licensing Dominance Continues, Driven by Atmos and Vision Growth — 10-K · Nov 18, 2025 Risk: medium
  Dolby Laboratories, Inc. (DLB) reported that licensing revenue constituted 93% of its total revenue for the fiscal year ended September 26, 2025, consistent wit
• Dolby Laboratories Files 8-K — 8-K · Nov 18, 2025 Risk: low
  Dolby Laboratories, Inc. filed an 8-K on November 18, 2025, reporting on its results of operations and financial condition, other events, and financial statemen
• 8-K Filing — 8-K · Nov 14, 2025
• Dolby Laboratories Files 8-K on Financials and Operations — 8-K · Jul 31, 2025 Risk: low
  Dolby Laboratories, Inc. filed an 8-K on July 31, 2025, reporting on its results of operations and financial condition, as well as other events. The filing also
• Dolby's Q3 Revenue Dips Amid Licensing Slowdown — 10-Q · Jul 31, 2025 Risk: medium
  Dolby Laboratories, Inc. reported total revenue of $290.0 million for the three months ended June 27, 2025, a decrease from $300.0 million in the prior-year per
• Dolby Laboratories Files 8-K on Financials and Operations — 8-K · May 1, 2025 Risk: low
  On May 1, 2025, Dolby Laboratories, Inc. filed an 8-K report. The filing indicates that the company is providing information regarding its results of operations
• Dolby Labs Files 10-Q for Q2 2025 — 10-Q · May 1, 2025 Risk: low
  Dolby Laboratories, Inc. filed its 10-Q for the period ending March 28, 2025. The filing details financial performance and operational updates for the quarter.
• Dolby Laboratories Files 8-K: Fiscal Year Change & Shareholder Votes — 8-K · Feb 7, 2025 Risk: low
  Dolby Laboratories, Inc. filed an 8-K on February 7, 2025, reporting events that occurred on February 4, 2025. The filing indicates a change in the company's fi
• Dolby Labs Files Q1 FY25 10-Q — 10-Q · Jan 30, 2025 Risk: low
  Dolby Laboratories, Inc. filed its 10-Q for the period ending December 27, 2024. The company reported its financial results for the first quarter of fiscal year
• Dolby Laboratories Files 8-K Report — 8-K · Jan 29, 2025 Risk: low
  On January 29, 2025, Dolby Laboratories, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, al
• Dolby Labs DEF 14A: Executive Compensation Details — DEF 14A · Dec 20, 2024 Risk: low
  Dolby Laboratories, Inc. filed its DEF 14A on December 20, 2024, for the fiscal year ending September 27, 2025. The filing details executive compensation and ot
• Dolby Laboratories Enters Material Agreement, Reports Financials — 8-K · Nov 19, 2024 Risk: medium
  On November 14, 2024, Dolby Laboratories, Inc. entered into a material definitive agreement. The company also reported its results of operations and financial c
• Dolby Laboratories Files 2024 Annual Report — 10-K · Nov 19, 2024 Risk: low
  Dolby Laboratories, Inc. filed its 10-K for the fiscal year ending September 27, 2024. The company, headquartered at 1275 Market Street, San Francisco, CA, repo
• Dolby Labs Files 8-K on Officer Changes & Financials — 8-K · Nov 15, 2024 Risk: low
  Dolby Laboratories, Inc. filed an 8-K on November 15, 2024, reporting events as of November 12, 2024. The filing pertains to the departure of directors or certa
• SC 13G/A Filing — SC 13G/A · Nov 13, 2024
• SC 13G/A Filing — SC 13G/A · Sep 10, 2024
• Dolby Laboratories Files 8-K — 8-K · Aug 19, 2024 Risk: low
  Dolby Laboratories, Inc. filed an 8-K on August 19, 2024, to report other events and financial statements. The filing does not contain specific details about ne
• Dolby Laboratories Files 8-K on Financials and Operations — 8-K · Aug 7, 2024 Risk: low
  Dolby Laboratories, Inc. filed an 8-K on August 7, 2024, reporting on its results of operations and financial condition, as well as other events. The filing inc
• Dolby Labs Files Q3 2024 10-Q — 10-Q · Aug 7, 2024 Risk: low
  Dolby Laboratories, Inc. filed its 10-Q for the period ending June 28, 2024. The filing details financial performance and operational updates for the third quar
• Dolby Laboratories Files 8-K — 8-K · Jun 6, 2024 Risk: low
  Dolby Laboratories, Inc. filed an 8-K on June 6, 2024, to report information under Regulation FD and to file financial statements and exhibits. The filing does
• Dolby Laboratories Files 8-K on Financials and Operations — 8-K · May 2, 2024 Risk: low
  Dolby Laboratories, Inc. filed an 8-K on May 2, 2024, to report on its results of operations and financial condition, as well as other events. The filing also i
• Dolby Laboratories, Inc. Files 10-Q for Period Ending March 29, 2024 — 10-Q · May 2, 2024 Risk: medium
  Dolby Laboratories, Inc. (DLB) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. Dolby Laboratories, Inc. filed a 10-Q report for the period ending M
• SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Dolby Labs Files 8-K on Shareholder Vote, Other Events — 8-K · Feb 9, 2024 Risk: medium
  Dolby Laboratories, Inc. filed an 8-K on February 9, 2024, reporting an event that occurred on February 6, 2024. This filing indicates the company submitted mat
• Morgan Stanley Amends Dolby Labs Stake to 5.0% — SC 13G/A · Feb 8, 2024 Risk: low
  Morgan Stanley filed an amended Schedule 13G/A on February 8, 2024, indicating a change in their beneficial ownership of Dolby Laboratories, Inc. Class A Common
• Dolby Laboratories, Inc. Files 10-Q for Period Ending December 29, 2023 — 10-Q · Feb 2, 2024 Risk: low
  Dolby Laboratories, Inc. (DLB) filed a Quarterly Report (10-Q) with the SEC on February 2, 2024. Dolby Laboratories, Inc. filed a 10-Q report for the period end
• Dolby Labs Files 8-K on Financial Condition & Operations — 8-K · Feb 1, 2024
  Dolby Laboratories, Inc. filed an 8-K on February 1, 2024, to report its financial condition and other events. This filing indicates that the company is providi
• BlackRock Amends Dolby Labs Stake, Maintains Significant Holding — SC 13G/A · Jan 24, 2024
  BlackRock Inc. filed an amended SC 13G/A on January 24, 2024, disclosing its ownership of Dolby Laboratories, Inc. Class A Common Stock as of December 31, 2023.

Risk Profile

Risk Assessment: Of DLB's 23 recent filings, 0 were flagged as high-risk, 6 as medium-risk, and 17 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Dolby Laboratories, INC.'s most recent 10-K filing (Nov 18, 2025):

• Revenue: Not Disclosed
• Net Income: Not Disclosed
• EPS: Not Disclosed
• Debt-to-Equity: Not Disclosed
• Cash Position: Not Disclosed
• Operating Margin: Not Disclosed
• Total Assets: Not Disclosed
• Total Debt: Not Disclosed

Key Executives

• Kevin Yeaman
• Robert Park
• Andy Sherman
• John Couling
• Shriram Revankar
• Peter Gotcher
• David Dolby
• Emily Rollins

Industry Context

Dolby Laboratories operates in the audio, video, and broadcast technology sectors, providing solutions that enhance entertainment experiences. The industry is characterized by rapid technological advancements, increasing demand for high-quality audio and visual content across various platforms (streaming, gaming, cinema), and evolving consumer expectations for immersive experiences. Competition comes from both established technology players and emerging innovators in audio codecs, spatial audio, and video processing.

Top Tags

10-Q (5) · financials (5) · financial-reporting (4) · operations (4) · corporate-governance (4) · 8-K (3) · financial-condition (3) · sec-filing (3) · Audio Technology (2) · Intellectual Property (2)

Executive Compensation

From the most recent DEF 14A filing (Dec 16, 2025):

• Kevin Yeaman — President and CEO

Key Numbers

• Total Revenue Fiscal 2025: $1.35 billion — Increased 6.3% from Fiscal 2024
• Net Income Fiscal 2025: $255.0 million — Decreased 2.6% from Fiscal 2024
• Non-GAAP Net Income Fiscal 2025: $413.5 million — Increased 12.1% from Fiscal 2024
• Diluted Earnings Per Share Fiscal 2025: $2.62 — Decreased 2.6% from Fiscal 2024
• Non-GAAP Diluted Earnings Per Share Fiscal 2025: $4.24 — Increased 11.9% from Fiscal 2024
• Quarterly Dividend Per Share: $0.36 — Increased 9% from $0.33 in November 2025
• Annual Incentive Compensation Multiplier: 94% — Based on fiscal 2025 revenue and non-GAAP operating income achievement
• Non-GAAP Operating Income Fiscal 2025: $447.5 million — Exceeded the $337.5 million gate for bonus plan
• Annualized Relative TSR: -9.88% — For performance stock units granted in fiscal 2022, relative to S&P Midcap 400 Index
• Vesting Percentage of Performance Stock Units: 70.37% — For awards granted in fiscal 2022, based on TSR performance
• Licensing Revenue Percentage: 93% — Percentage of total revenue for fiscal year ended September 26, 2025, consistent with fiscal 2024.
• Products and Services Revenue Percentage: 7% — Percentage of total revenue for fiscal year ended September 26, 2025.
• Market Value of Non-Affiliate Voting Common Equity: $3.0 billion — As of March 28, 2025.
• Class A Common Stock Shares Outstanding: 60,845,846 — As of October 24, 2025.
• Class B Common Stock Shares Outstanding: 34,660,045 — As of October 24, 2025.

Forward-Looking Statements

• {"claim":"Morgan Stanley will maintain a significant, but potentially fluctuating, stake in Dolby Laboratories, Inc. Class A Common Stock.","entity":"Morgan Stanley","targetDate":"Q2 2024","confidence":"medium"}

Related Companies

^MID · DTS · MSFT · AAPL

Frequently Asked Questions